secwatch.observer — SEC 8-K summary
======================================

Issuer:     Trevi Therapeutics, Inc. (TRVI)
CIK:        0001563880
Form:       8-K
Filed at:   2022-03-16T23:59:59+00:00
Accession:  0001564590-22-010637
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Trevi Therapeutics regains Nasdaq minimum bid price compliance
--------------------------------------------------------------

- Received Nasdaq deficiency letter on Jan 10, 2022 for bid price below $1 for 30 consecutive days.
- Compliance regained after closing bid price above $1 for ten consecutive business days (March 2-15, 2022).
- Nasdaq notified company on March 16, 2022 that the matter is closed.
- Company's common stock remains listed on Nasdaq Global Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563880/000156459022010637/0001564590-22-010637-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563880/000156459022010637/trvi-8k_20220316.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-010637

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer